Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.5.4, replacing the previous revision tag. This indicates a small, behind-the-scenes update to the page version rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:28.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s displayed revision/version indicator was updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:26:52.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Results have been posted for the study, with corresponding QC dates noted. A PDF of the Study Protocol and Statistical Analysis Plan has been added to Study Documents.
    Difference
    1%
    Check dated 2026-03-29T00:28:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; the page now reflects the newer revision label.
    Difference
    0.1%
    Check dated 2026-03-21T17:04:01.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T04:13:01.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' in the Results section, replacing the previous 'No Results Posted' status.
    Difference
    0.1%
    Check dated 2026-02-20T20:25:11.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.